tiprankstipranks
Trending News
More News >
Next Science Ltd (NXSCF)
:NXSCF

Next Science Ltd (NXSCF) Price & Analysis

Compare
8 Followers

NXSCF Stock Chart & Stats

$0.08
<$0.01(13.82%)
At close: 4:00 PM EST
$0.08
<$0.01(13.82%)

Next Science Ltd News

NXSCF FAQ

What was Next Science Ltd’s price range in the past 12 months?
Next Science Ltd lowest stock price was $0.02 and its highest was $0.11 in the past 12 months.
    What is Next Science Ltd’s market cap?
    Next Science Ltd’s market cap is $27.16M.
      When is Next Science Ltd’s upcoming earnings report date?
      Next Science Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 73 days.
        How were Next Science Ltd’s earnings last quarter?
        Next Science Ltd released its earnings results on Aug 28, 2025. The company reported -$0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.016.
          Is Next Science Ltd overvalued?
          According to Wall Street analysts Next Science Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Next Science Ltd pay dividends?
            Next Science Ltd does not currently pay dividends.
            What is Next Science Ltd’s EPS estimate?
            Next Science Ltd’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Next Science Ltd have?
            Next Science Ltd has 292,625,370 shares outstanding.
              What happened to Next Science Ltd’s price movement after its last earnings report?
              Next Science Ltd reported an EPS of -$0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Next Science Ltd?
                Currently, no hedge funds are holding shares in NXSCF
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Next Science Ltd Stock Smart Score

                  4
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  14.28%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -289.70%
                  Trailing 12-Months
                  Asset Growth
                  -19.99%
                  Trailing 12-Months

                  Company Description

                  Next Science Ltd

                  Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site infections. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia.

                  Next Science Ltd (NXSCF) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Little Green Pharma Ltd.
                  Medical Developments International Limited
                  Althea Group Holdings Ltd.
                  IDT Australia Limited
                  Cronos Australia Ltd.

                  Ownership Overview

                  0.39%<0.01%99.61%
                  <0.01% Other Institutional Investors
                  99.61% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks